5 November 2014- Mont saint Guibert, Belgium
The belgian biotech Cardio3 BioSciences, leader in the discovery and development of regenerative, protective and reconstructive therapies, announces today that it has acquired U.S.-based CorQuest Medical Inc.
CorQuest Medical, based in Miami, but incorporated in Delaware in July 2012, specializes in the development of innovative devices and technologies for cardiac surgery. It was founded by a Belgian, Dr. Didier De Cannière.
Euronext Brussels and Paris: CARD
This comment has been removed by a blog administrator.
ReplyDelete